ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

MACUGEN
Miscellaneous ocular agents
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

MACUGEN Rx

Generic Name and Formulations:
Pegaptanib sodium 0.3mg/prefilled syringe; soln for oph intravitreous inj; preservative-free.

Company:
Valeant Pharmaceuticals, Inc

Therapeutic Use:

Indications for MACUGEN:

Treatment of neovascular (wet) age-related macular degeneration.

Adult:

Give by intravitreous inj. 0.3mg once every 6 weeks into the eye to be treated.

Children:

Not recommended.

Contraindications:

Ocular or periocular infections.

Warnings/Precautions:

Monitor for infection during week following inj (endophthalmitis possible). Monitor intraocular pressure and perfusion of optic nerve. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Vascular endothelial growth factor (VEGF) inhibitor.

Adverse Reactions:

Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, hypertension, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbances, vitreous floaters, vitreous opacities, blepharitis, conjunctivitis, photopsia, bronchitis, diarrhea, dizziness, headache, nausea, UTI, others.

How Supplied:

Pre-filled syringe—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs